OKYO PHARMA LTD (OKYO:NASDAQ)
$1.69 0.01 (0.5952%)
Analysed OKYO PHARMA LTD (OKYO:NASDAQ) News Sources
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
29-04-2026
yahoo.com
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
19-05-2026
yahoo.com
OKYO Pharma adds ophthalmology specialist Marta Sacchetti to Scientific Advisory Board
19-05-2026
proactiveinvestors.com
OKYO Pharma Strengthens Scientific Advisory Board With Marta Sacchetti Appointment
19-05-2026
yahoo.com
What Makes OKYO Pharma (OKYO) a New Buy Stock
20-05-2026
yahoo.com
OKYO Pharma expands scientific advisory board with cornea expert - ICYMI
23-05-2026
proactiveinvestors.com
OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
07-07-2026
yahoo.com
OKYO Pharma clears key FDA milestone, advances toward Phase 3 trial for Neuropathic corneal pain
07-07-2026
yahoo.com
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08-07-2026
yahoo.com
OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain
08-07-2026
proactiveinvestors.com
What is the current price of OKYO PHARMA LTD (OKYO:NASDAQ)?
The current price of OKYO PHARMA LTD (OKYO:NASDAQ) is $1.69.
OKYO PHARMA LTD (OKYO:NASDAQ) absolute price change since previous trading day?
The absolute price change of OKYO PHARMA LTD (OKYO:NASDAQ) since the previous trading day is $0.01.
OKYO PHARMA LTD (OKYO:NASDAQ) percentage price change since previous trading day?
The percentage price change of OKYO PHARMA LTD (OKYO:NASDAQ) since the previous trading day is 0.5952%.
What is the most recent average sentiment score for OKYO PHARMA LTD (OKYO:NASDAQ)?
The most recent average sentiment score for OKYO PHARMA LTD (OKYO:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for OKYO PHARMA LTD (OKYO:NASDAQ)?
The most recent sentiment for OKYO PHARMA LTD (OKYO:NASDAQ) is .
SEC-8K** Filing Available For OKYO PHARMA LTD (OKYO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.